Dear Dr. Baughman,
Thank you for your quick response to my question. Our daughter was diagnosed
as hypothyroid
[Fred A. Baughman Jr., MD:
a real disease]
at age 11, having lost 3 years bone growth. She has suffered
learning disabilities and receives thyroid hormone
[Fred A. Baughman Jr., MD:
necessary, justifiable medical treatment]
.
In 1998 she had a CT scan because of her decreased sense of smell. It was
normal
[Fred A. Baughman Jr., MD:
what is birth date, age at first CT]
. The same year
her doctor started her on Paxil
[Fred A. Baughman Jr., MD:
not nececessary, justifiable medical
treatment because anxiety, no matter how defined, is not a disease due to an
abnormality within the individual]
because of anxiety. 18
months later Buspirone (an anti-anxiety, azaspirodecanedione) was added
and Paxil was switched to Celexa (citalopram, another SSRI)
[Fred A. Baughman Jr., MD:
none of
these three psychotropic drugs are necessary, justifiable medical treatment
because no psychiatric disorder whatsoever, schizophrenia included, is
known/proved to be an organic disease/abnormality of the brain]
.
Now, 3
1/2 years later, at the age of 29, our daughter has lost many of the
skills
she used to have. She is forgetful and confused, ( her full scale IQ has
decreased by 17 points since the last test in 1992) she cannot even run
the
bath for herself as she cannot regulate the water temp. She is like a
different person
[Fred A. Baughman Jr., MD:
sounds, from symptoms you describe, like a
progressive, organic brain syndrome/demential]
. You should know that she
lived alone in her own apartment
for two years (around 1996 & 1997) receiving help from Community Living
Services.
After a consult with the local psychologist in June, 2002, it was
recommended we compare the recent CT scan with the one done in '98. The
result is "general brain atrophy". Hence the question about drug induced
brain damage.
[Fred A. Baughman Jr., MD:
everything considered, she needs (if she has not
had) a current consultation with a neurologist. Consider having her seen by
a neurologist with a university affiliation/appointment. Keep me posted. I
assume here thyroid status has been rechecked over the years.
Hypothyroidism, including undertreated hypothyroidism can cause organic
brain syndrome/dementia. Good luck, FB]
I hope this info helps, we appreciate the work that you do.
Joy P
Check this:
Subject:
Fwd: PROZAC MAY STUNT GROWTH
Date:
Tue, 29 Feb 2000 13:14:13 EST
From:
HValent917@aol.com
To:
drjv@learning-revolution.com, admccull@inasec.ca,
webmaster@mentalhealthfacts.com, GALEANN@aol.com, GubbyGus@aol.com,
fred-alden@att.net, JDave52@aol.com, donaldleeper@pacific.net,
djfr@email.msn.com, drutle@bellsouth.net, RICE7559@tao.sou.edu,
cuckoo@mindspring.com, NO20@cornell.edu, SSahni8396@aol.com,
howe@slip.net,
In a message dated 2/28/00 1:58:14 AM Pacific Standard Time, Ian@Goddard.net
writes:
[Fred A. Baughman Jr., MD:
not unlike
Ritalin/amphetamine treatment which disrupt growth hormone and cause
diminished height and weight, and, probably, diminished growth of all
organs, the brain included. The MRI brain scan literature on ADHD, from
1986 to the present show the subjects brains to be on-average 10% atrophic
relative to those of normal control subjects. In that ADHD has yet to be
validated as a disease/abnormality, leaving their Ritalin/amphetamine
treatment the only known physical variable and in that all of the ADHD
subject-groups were "treated" it is impossible to conclude other than that
their stimulant treatment has been the cause of their brain atrophy. These
are dangers US psychiatry and the pharmaceutical industry keep from
us.]
While it may be too early to draw definitive conclusions
regarding the effect of SSRIs on human growth, the available
evidence clearly points to the likelihood of a detrimental
impact. The available evidence also raises this most-
important question: If Prozac and other SSRIs reduce the
growth of infants, then what effect might they have on the
development of growing children and young adults, who are
increasingly targeted for antidepressant treatment? 1
Furthermore, since the evidence suggests Prozac may stunt
growth, is it ethical to expose growing children to SSRIs?
___________________________________________________________
1 Zito, J. M., Safer, D. J., dosReis, S., et al. (2000)
Trends in the Prescribing of Psychotropic Medications to
Preschoolers. Journal of the American Medical Association,
283(8). http://jama.ama-assn.org/issues/v283n8/full/joc91250.html
2 Chambers, C. D., Anderson, P. O., Thomas, R. G., et al.
(1999). Weight Gain in Infants Breastfed by Mothers Who Take
Fluoxetine. Pediatrics, 104(5):e61.
http://www.pediatrics.org/cgi/content/full/104/5/e61
3 Chambers, C. D., Johnson, K. A., Dick, L. M., et al.
(1996). Birth outcomes in pregnant women taking fluoxetine.
New England Journal of Medicine, 335(14):1010-5.
4 da-Silva, V. A., Altenburg, S. P., Malheiros, L. R., et al.
(1999). Postnatal development of rats exposed to fluoxetine or
venlafaxine during the third week of pregnancy. Brazilian
Journal of Medical and Biological Research, 32(1):93-8.
5 Jensen, J. B., Jessop, D. S., Harbuz, M. S. (1999). Acute
and long-term treatments with the selective serotonin reuptake
inhibitor citalopram modulate the HPA axis activity at different
levels in male rats. Journal of Neuroendocrinology, 11(6):465-71.
6 Lerer, B., Gelfin, Y., Gorfine, M., et al. (1999). 5-HT1A
receptor function in normal subjects on clinical doses of fluoxetine:
blunted temperature and hormone responses to ipsapirone challenge.
Neuropsychopharmacology, Jun;20(6):628-39.
7 Anderson, I. M., Deakin, J. F., Miller, H. E., (1996). The
effect of chronic fluvoxamine on hormonal and psychological
responses to buspirone in normal volunteers. Psychopharmacology,
(Berl), 128(1):74-82.
8 O'Flynn, K., O'Keane, V., Lucey, J. V., Dinan, T. G., (1991).
Effect of fluoxetine on noradrenergic mediated growth hormone
release: a double blind, placebo-controlled study. Biological
Psychiatry, 15;30(4):377-82.
9 Serri, O., Rasio, E. (1987). The effect of d-fenfluramine
on anterior pituitary hormone release in the rat: in vivo and
in vitro studies. Canadian Journal of Physiology and
Pharmacology, 65(12):2449-53.
Find these studies here: http://www.ncbi.nlm.nih.gov/PubMed
Additional Drug Reports From Goddard's Journal:
LOOKING FOR "EARLY SCHIZOPHRENIA" IN CHILDREN
MAY INCREASE RISK OF IATROGENIC POLYPHARMACY:
http://users.erols.com/igoddard/polyrisk.htm
Letter From Peter Breggin, MD, to JAMA:
http://users.erols.com/igoddard/breggin.htm
The Mass Drugging of Children:
http://www.erols.com/igoddard/massdrug.htm
Exposing Kids to Brain Damage Risk:
http://www.erols.com/igoddard/atrophy1.htm
Does Making Kids Take Drugs Violate Anti-Nazi
Law? http://www.erols.com/igoddard/nazi-rit.htm
------------------------------------------------------------
GODDARD'S JOURNAL: http://www.erols.com/igoddard/journal.htm
____________________________________________________________
----------------------- Headers --------------------------------
Return-Path:
|
